Summary

The global medical robots market is projected to reach USD 41.7 billion in 2031 from USD 20.6 billion in 2026, at a CAGR of 15.1% during the forecast period. The medical robots market is expected to witness strong growth, driven by a combination of clinical, technological, and healthcare automation factors. The rising prevalence of chronic diseases, growing geriatric population, and increasing demand for minimally invasive and precision-based procedures continue to support the adoption of robotic-assisted solutions across healthcare settings. Technological advancements in surgical robotics, rehabilitation robots, hospital and pharmacy automation systems, and non-invasive radiosurgery platforms have improved procedural accuracy, workflow efficiency, medication management, and patient outcomes, thereby accelerating adoption among hospitals, clinics, pharmacies, and rehabilitation centers. Furthermore, the growing need to minimize medication errors, reduce procedural variability, optimize healthcare workflows, and address workforce constraints is contributing to market expansion. These trends are expected to sustain strong growth momentum across both developed and emerging economies; however, stringent regulatory requirements, high system costs, maintenance expenses, and the need for specialized training may restrain adoption to some extent over the forecast period. The robotic systems segment is expected to account for the highest market share during the forecast period. Based on products & services, the medical robots market is segmented into robotic systems, instruments & accessories, and services. The robotic systems segment is projected to account for the highest market share during the forecast period. The high share in this segment can be attributed to the growing focus on adopting technologically advanced surgical robots and robotic-assisted platforms among end users. The increasing demand for precision-based, minimally invasive procedures and the integration of AI, imaging, navigation, and data-driven capabilities are further supporting the adoption of advanced robotic systems. In addition, expanding hospital investments in automation and next-generation robotic platforms are expected to strengthen demand for robotic systems across surgical, rehabilitation, radiosurgery, and hospital automation applications. The surgical robotic system segment is estimated to hold the largest share of the medical robots market by type. Based on type, the medical robots market is segmented into surgical robotic systems, rehabilitation robotic systems, radiosurgery robotic systems, hospital robotic systems, and pharmacy robotic systems. The surgical robotic systems have been further segmented by application into soft tissue surgery (general surgery, gynecological surgery, urological surgery and other applications) and hard tissue surgery (knee & hip surgery, spine surgery, and other applications). The surgical robotic systems segment accounted for the largest share of the medical robots market in 2025. This segment is expected to witness significant growth due to the increasing demand for surgeries, rising global surgical volumes, and growing clinical acceptance of surgical robots. The expanding adoption of minimally invasive procedures, improved surgeon control, enhanced visualization, and higher procedural precision are further supporting the uptake of surgical robotic systems across hospitals and specialty surgical centers. The ambulatory surgery centers segment is expected to register the highest growth during the forecast period. Based on end user, the medical robots market is segmented into hospitals & clinics, ambulatory surgery centers, pharmacies, rehabilitation centers, and other end users. The ambulatory surgery centers segment is projected to witness the highest growth rate during the forecast period. Growth in this segment is primarily driven by the increasing shift of suitable surgical procedures from inpatient hospital settings to outpatient care environments, supported by the potential for lower treatment costs, shorter patient stays, and faster recovery timelines. The rising demand for efficient, high-quality, and minimally invasive surgical care is encouraging ambulatory surgery centers to adopt advanced robotic-assisted technologies. Asia Pacific is projected to register the highest growth in the medical robots market during the forecast period. The global medical robots market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2025, Asia Pacific is expected to register the highest growth in the medical robots market during the forecast period. Factors such as the increasing adoption of surgical robots, a large patient pool, rising disposable incomes, and growing willingness to spend on advanced healthcare solutions are expected to support market growth in the region. In addition, rapid technological adoption, advancements in the healthcare sector, expansion of private healthcare facilities, and government focus on improving healthcare infrastructure are further expected to drive the growth of the medical robots market in Asia Pacific. Breakdown of primary interviews: • By Supply Side: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%) • By Designation: C-level Executives (45%), Directors (35%), and Others (20%) • By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and Middle East and Africa (10%) The prominent players in this market are Intuitive Surgical, Inc (US), Stryker (US), Becton, Dickinson and Company (US), Medtronic (Ireland), Omnicell, LLC (US), Zimmer Biomet (US), Smith & Nephew (UK), Ekso Bionics Holdings, Inc. (US), ARxIUM (Canada), Asensus Surgical (US), Renishaw Plc (UK), ZAP Surgical Systems, Inc. (US), KUKA SE & Co. KGaA (Germany), CMR Surgical (UK), Accuray Incorporated (US), DIH Medical (Switzerland), Johnson & Johnson (US), Cyberdyne Inc. (Japan), Lifeward, Inc. (Israel), Relay Robotics (US), Aethon, Inc. (US), Xenex Disinfection Services, Inc. (US), Stereotaxis, Inc. (US), PROCEPT BioRobotics Corporation (US), and Globus Medical (US). Players adopted organic as well as inorganic growth strategies such as acquisitions, product launches, expansions, agreements & collaborations, and approvals to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market. Research Coverage The report studies the medical robots market based on product & service, type, end user, and region. The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total medical robots market. The report forecasts the revenue of market segments with respect to five major regions. Reasons to Buy the Report The report provides valuable insights for market leaders and new entrants in the medical robots industry, offering approximate revenue figures for the overall market and its subsegments. It assists stakeholders in understanding the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report highlights key market drivers, restraints, challenges, and opportunities, helping stakeholders gauge the current state of the market This report provides insights into the following pointers:  Analysis of key drivers (aging population and rising chronic diseases, technological advancements, increasing need for automation in healthcare, improving reimbursement scenario, and advancements in healthcare funding & infrastructure, and growing need to minimize medication errors), restraints (high cost of robotic systems and stringent regulatory requirements), opportunities (growth opportunities in emerging markets, and novel application) and challenge (patient and provider acceptance).  Market Penetration: It provides detailed information on the product portfolios offered by major players in the global medical robots market. The report covers various segments, including product & service, type, region, and end user.  Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the medical robots market.  Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of medical robot solutions across regions.  Market Diversification: Exhaustive information about solutions, untapped regions, recent developments, and investments in the medical robots market.  Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and capabilities of the leading players in the medical robots market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 MARKET SCOPE 35
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 35
1.3.2 INCLUSIONS AND EXCLUSIONS 36
1.3.3 YEARS CONSIDERED FOR STUDY 37
1.4 CURRENCY 37
1.5 STAKEHOLDERS 38
1.6 SUMMARY OF CHANGES 38
1.6.1 REFINEMENTS IN SCOPE 38
1.6.2 COVERAGE OF NEW PLAYERS 38
1.6.3 UPDATED MARKET DEVELOPMENTS OF PROFILED PLAYERS 38
1.6.4 UPDATED FINANCIAL INFORMATION/PRODUCT PORTFOLIOS OF PLAYERS 39
1.6.5 UPDATED GEOGRAPHIC ANALYSIS 39
2 EXECUTIVE SUMMARY 40
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 40
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 42
2.3 DISRUPTIVE TRENDS IN MEDICAL ROBOTS MARKET 43
2.4 HIGH-GROWTH SEGMENTS 44
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 45
3 PREMIUM INSIGHTS 46
3.1 MEDICAL ROBOTS MARKET OVERVIEW 46
3.2 MEDICAL ROBOTS MARKET, BY REGION 47
3.3 ASIA PACIFIC MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE AND COUNTRY 48
3.4 GEOGRAPHIC SNAPSHOT OF MEDICAL ROBOTS MARKET 49
3.5 MEDICAL ROBOTS MARKET: DEVELOPING VS. DEVELOPED MARKETS 49
4 MARKET OVERVIEW 50
4.1 INTRODUCTION 50
4.2 MARKET DYNAMICS 50
4.2.1 DRIVERS 51
4.2.1.1 Increasing geriatric population with chronic diseases 51
4.2.1.2 Technological advancements in medical robotics 52
4.2.1.3 Growing need for automation in healthcare 53
4.2.1.4 Favorable reimbursement scenario for surgical robots from third-party payers 53
4.2.1.5 Advancements in healthcare funding and infrastructure 54
4.2.1.6 Rising need to minimize medication and dispensing errors 55
4.2.2 RESTRAINTS 55
4.2.2.1 High cost of medical robotic systems 55
4.2.2.2 Stringent regulatory requirements and delays in product approvals 56
4.2.3 OPPORTUNITIES 56
4.2.3.1 High growth opportunities in emerging economies 56
4.2.3.2 Increased use of robotics in novel applications 57
4.2.4 CHALLENGES 57
4.2.4.1 Need to ensure patient and provider acceptance 57
4.3 UNMET NEEDS AND WHITE SPACES 58
4.3.1 UNMET NEEDS IN MEDICAL ROBOTS MARKET 58
4.3.2 WHITE SPACE OPPORTUNITIES 58
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 59
4.4.1 INTERCONNECTED MARKETS 59
4.4.2 CROSS-SECTOR OPPORTUNITIES 60
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 61
5 INDUSTRY TRENDS 62
5.1 PORTER’S FIVE FORCES ANALYSIS 62
5.1.1 BARGAINING POWER OF SUPPLIERS 63
5.1.2 BARGAINING POWER OF BUYERS 64
5.1.3 THREAT OF NEW ENTRANTS 64
5.1.4 THREAT OF SUBSTITUTES 64
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 64
5.2 MACROECONOMIC OUTLOOK 65
5.2.1 INTRODUCTION 65
5.2.2 GDP TRENDS AND FORECAST 65
5.2.3 TRENDS IN GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY 67
5.3 REIMBURSEMENT SCENARIO ANALYSIS 67
5.4 VALUE CHAIN ANALYSIS 70
5.5 ECOSYSTEM ANALYSIS 71
5.6 PRICING ANALYSIS 72
5.6.1 AVERAGE SELLING PRICE TREND, BY REGION 72
5.6.2 AVERAGE SELLING PRICE TREND OF MEDICAL ROBOTS, BY TYPE 73
5.7 TRADE ANALYSIS 73
5.7.1 IMPORT DATA FOR HS CODE 901890 73
5.7.2 EXPORT DATA FOR HS CODE 901890 74
5.8 KEY CONFERENCES & EVENTS, 2026–2027 74
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 75
5.10 CASE STUDY ANALYSIS 76
5.10.1 CASE STUDY 1: DR. MOHIT BHANDARI PERFORMS WORLD'S FIRST TRANSCONTINENTAL ROBOTIC BARIATRIC SURGERY USING SSI MANTRA 76
5.10.2 CASE STUDY 2: SUTTER HEALTH PERFORMS FIRST US ROBOTIC SINGLE-PORT NIPPLE-SPARING MASTECTOMY 76
5.10.3 CASE STUDY 3: ST JOHN OF GOD GEELONG EXPANDS ACCESS TO ADVANCED ROBOTIC SURGERY 77
5.11 INVESTMENT AND FUNDING SCENARIO 77
5.12 IMPACT OF 2025 US TARIFF ON MEDICAL ROBOTS MARKET 78
5.12.1 INTRODUCTION 78
5.12.2 KEY TARIFF RATES 78
5.12.3 PRICE IMPACT ANALYSIS 79
5.12.4 IMPACT ON COUNTRY/REGION 79
5.12.4.1 US 79
5.12.4.2 Europe 80
5.12.4.3 Asia Pacific 80
5.12.5 IMPACT ON END-USE INDUSTRIES 80
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS,
AND INNOVATIONS 81
6.1 KEY EMERGING TECHNOLOGIES 81
6.1.1 ROBOTIC ARMS AND INSTRUMENTS 81
6.1.2 ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML) 81
6.1.3 TELEPRESENCE 81
6.1.4 REHABILITATION ROBOTICS & WEARABLE EXOSKELETON TECHNOLOGIES 81
6.1.5 PHARMACY AUTOMATION & INTELLIGENT MEDICATION MANAGEMENT 81
6.1.6 COMPLEMENTARY TECHNOLOGIES 82
6.1.6.1 Augmented reality (AR) and virtual reality (VR) 82
6.1.6.2 3D imaging 82
6.2 TECHNOLOGY/PRODUCT ROADMAP 82
6.2.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 82
6.2.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 83
6.2.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 84
6.3 PATENT ANALYSIS 85
6.4 IMPACT OF AI/GEN AI ON MEDICAL ROBOTS MARKET 86
6.4.1 TOP USE CASES AND MARKET POTENTIAL 87
6.4.2 BEST PRACTICES IN MEDICAL ROBOT DEPLOYMENT AND PROCESSING 87
6.4.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL ROBOTS MARKET 88
6.4.4 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS 89
6.4.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MEDICAL ROBOTS MARKET 89
7 REGULATORY LANDSCAPE 90
7.1 REGIONAL REGULATIONS AND COMPLIANCE 90
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
7.2 REGULATORY FRAMEWORK 93
7.2.1 NORTH AMERICA 93
7.2.1.1 US 93
7.2.2 EUROPE 94
7.2.3 ASIA PACIFIC 94
7.2.3.1 Japan 94
7.2.3.2 China 95
7.2.3.3 India 96
7.2.3.4 Latin America 96
7.2.3.4.1 Brazil 96
7.2.3.4.2 Mexico 96
7.2.3.5 Middle East 97
7.2.3.6 Africa 97
7.2.4 INDUSTRY STANDARDS 97
7.3 CERTIFICATIONS, LABELING, & ECO-STANDARDS 98
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 100
8.1 DECISION-MAKING PROCESS 100
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 100
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 100
8.2.2 BUYING CRITERIA 101
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 102
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 103
8.5 MARKET PROFITABILITY 103
8.5.1 REVENUE POTENTIAL 104
8.5.2 COST DYNAMICS 104
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 104
9 MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE 105
9.1 INTRODUCTION 106
9.2 INSTRUMENTS & ACCESSORIES 106
9.2.1 NEED FOR RECURRENT PURCHASE OF INSTRUMENTS & ACCESSORIES FOR SURGICAL PROCEDURES TO SUPPORT MARKET GROWTH 106
9.3 ROBOTIC SYSTEMS 108
9.3.1 INCREASING ADOPTION OF TECHNOLOGICALLY ADVANCED ROBOTIC SYSTEMS TO DRIVE MARKET 108
9.4 SERVICES 109
9.4.1 INCREASED DEMAND FOR ANNUAL MAINTENANCE CONTRACTS, TECHNICAL SUPPORT, AND USER TRAINING TO PROPEL MARKET 109
10 MEDICAL ROBOTS MARKET, BY TYPE 111
10.1 INTRODUCTION 112
10.2 SURGICAL ROBOTIC SYSTEMS 113
10.2.1 SOFT TISSUE SURGERY 114
10.2.1.1 General surgery 116
10.2.1.1.1 Increasing prevalence of diseases to drive market 116
10.2.1.2 Gynecological surgery 117
10.2.1.2.1 Increased availability of robotic platforms to increase adoption of robot-assisted gynecological surgeries 117
10.2.1.3 Urological surgery 119
10.2.1.3.1 Increasing prevalence of urological cancers to drive market 119
10.2.1.4 Other soft tissue surgeries 121
10.2.2 HARD TISSUE SURGERY 123
10.2.2.1 Knee & hip surgery 124
10.2.2.1.1 Increasing number of knee & hip replacement surgeries to propel market 124
10.2.2.2 Spine surgery 127
10.2.2.2.1 Increasing adoption of robotic systems for spinal surgeries to drive market 127
10.2.2.3 Other hard tissue surgeries 128
10.3 REHABILITATION ROBOTIC SYSTEMS 129
10.3.1 THERAPEUTIC ROBOTIC SYSTEMS 131
10.3.1.1 Increasing cases of stroke to drive adoption 131
10.3.2 ASSISTIVE ROBOTIC SYSTEMS 132
10.3.2.1 Rising geriatric population to support market growth 132
10.3.3 EXOSKELETON ROBOTIC SYSTEMS 133
10.3.3.1 Rising patient pool of neurological disorders to support market growth 133
10.3.4 OTHER REHABILITATION ROBOTIC SYSTEMS 135
10.4 RADIOSURGERY ROBOTIC SYSTEMS 136
10.4.1 GROWING ADOPTION OF ADVANCED STEREOTACTIC RADIATION DELIVERY SYSTEMS BY HOSPITALS TO DRIVE MARKET 136
10.5 HOSPITAL ROBOTIC SYSTEMS 137
10.5.1 DELIVERY ROBOTIC SYSTEMS 138
10.5.1.1 Increasing patient population along with shortage of nursing staff to drive adoption 138
10.5.1.2 Telepresence robotic systems 140
10.5.1.2.1 Increased adoption of telepresence robotic systems to drive market 140
10.5.1.3 Diagnostic robotic systems 141
10.5.1.3.1 Shortage of skilled healthcare professionals to drive adoption 141
10.5.1.4 Other hospital robotic systems 143
10.6 PHARMACY ROBOTIC SYSTEMS 144
10.6.1 ROBOTIC DISPENSING SYSTEMS 145
10.6.1.1 High adoption of robots to reduce dispensing errors in hospitals to drive market 145
10.6.2 COMPOUNDING ROBOTIC SYSTEMS 147
10.6.2.1 Reduce cost per dose of medication and need for medication outsourcing 147
10.6.3 OTHER PHARMACY ROBOTIC SYSTEMS 148
11 MEDICAL ROBOTS MARKET, BY END USER 150
11.1 INTRODUCTION 151
11.2 HOSPITALS & CLINICS 151
11.2.1 HIGH NUMBER OF ROBOTIC-ASSISTED SURGERIES PERFORMED TO SUPPORT MARKET GROWTH 151
11.3 AMBULATORY SURGERY CENTERS 153
11.3.1 COST-EFFECTIVE TREATMENTS TO SUPPORT MARKET GROWTH 153
11.4 PHARMACIES 155
11.4.1 REDUCED MEDICATION ERRORS AND INCREASED EFFICIENCY TO DRIVE ADOPTION 155
11.5 REHABILITATION CENTERS 156
11.5.1 INCREASING INCIDENCE OF DISABILITIES TO SUPPORT MARKET GROWTH 156
11.6 OTHER END USERS 158
12 MEDICAL ROBOTS MARKET, BY REGION 160
12.1 INTRODUCTION 161
12.2 NORTH AMERICA 162
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 162
12.2.2 US 167
12.2.2.1 Presence of many established players to support strong adoption of medical robots 167
12.2.3 CANADA 171
12.2.3.1 Growing adoption of advanced healthcare solutions to propel market 171
12.3 EUROPE 174
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 175
12.3.2 GERMANY 178
12.3.2.1 Strong medical infrastructure to propel market growth 178
12.3.3 UK 182
12.3.3.1 National NHS expansion to accelerate medical robot adoption 182
12.3.4 FRANCE 186
12.3.4.1 Government-backed innovation and hospital adoption to drive growth 186
12.3.5 ITALY 190
12.3.5.1 Government support for healthcare innovation to propel market growth 190
12.3.6 SPAIN 193
12.3.6.1 Increasing healthcare spending to drive market 193
12.3.7 REST OF EUROPE 197
12.4 ASIA PACIFIC 201
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 202
12.4.2 JAPAN 206
12.4.2.1 Domestic innovation and reimbursement support to support market growth 206
12.4.3 CHINA 210
12.4.3.1 Government support for healthcare modernization to propel market 210
12.4.4 INDIA 214
12.4.4.1 Increasing healthcare investments to boost demand for medical robotic systems 214
12.4.5 SOUTH KOREA 217
12.4.5.1 Government investment and high-volume surgical centers to support market growth 217
12.4.6 AUSTRALIA 221
12.4.6.1 Rising adoption of robotic-assisted surgery to propel market 221
12.4.7 REST OF ASIA PACIFIC 225
12.5 LATIN AMERICA 228
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 229
12.5.2 BRAZIL 233
12.5.2.1 Expanding healthcare infrastructure to support adoption of medical robots 233
12.5.3 MEXICO 236
12.5.3.1 Need to reduce medication errors and rising geriatric population to drive market 236
12.5.4 REST OF LATIN AMERICA 239
12.6 MIDDLE EAST & AFRICA 243
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 243
12.6.2 GCC COUNTRIES 247
12.6.2.1 Increasing initiatives to drive demand for surgical robots 247
12.6.3 REST OF MIDDLE EAST & AFRICA 251
13 COMPETITIVE LANDSCAPE 255
13.1 INTRODUCTION 255
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 255
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL ROBOTS MARKET 255
13.3 REVENUE ANALYSIS, 2021–2025 257
13.4 MARKET SHARE ANALYSIS, 2025 258
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 262
13.5.1 STARS 262
13.5.2 EMERGING LEADERS 262
13.5.3 PERVASIVE PLAYERS 263
13.5.4 PARTICIPANTS 263
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 264
13.5.5.1 Company footprint 264
13.5.5.2 Region footprint 265
13.5.5.3 Product & service footprint 266
13.5.5.4 Type footprint 267
13.5.5.5 End-user footprint 268
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 269
13.6.1 PROGRESSIVE COMPANIES 269
13.6.2 RESPONSIVE COMPANIES 269
13.6.3 DYNAMIC COMPANIES 269
13.6.4 STARTING BLOCKS 269
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 271
13.6.5.1 Detailed list of key startups/SMEs 271
13.6.5.2 Competitive benchmarking of key startups/SMEs 271
13.7 BRAND COMPARISON 272
13.8 COMPANY VALUATION AND FINANCIAL METRICS 273
13.8.1 FINANCIAL METRICS 273
13.8.2 COMPANY VALUATION 273
13.9 COMPETITIVE SCENARIO 274
13.9.1 PRODUCT LAUNCHES & APPROVALS 274
13.9.2 DEALS 275
13.9.3 EXPANSIONS 276
13.9.4 OTHER DEVELOPMENTS 277
14 COMPANY PROFILES 278
14.1 KEY PLAYERS 278
14.1.1 INTUITIVE SURGICAL, INC. 278
14.1.1.1 Business overview 278
14.1.1.2 Products/Solutions/Services offered 279
14.1.1.3 Recent developments 281
14.1.1.3.1 Product approvals 281
14.1.1.3.2 Deals 282
14.1.1.3.3 Expansions 283
14.1.1.4 MnM view 283
14.1.1.4.1 Key strengths 283
14.1.1.4.2 Strategic choices 283
14.1.1.4.3 Weaknesses & competitive threats 283
14.1.2 STRYKER 284
14.1.2.1 Business overview 284
14.1.2.2 Products/Solutions/Services offered 285
14.1.2.3 Recent developments 286
14.1.2.3.1 Product launches 286
14.1.2.3.2 Deals 286
14.1.2.3.3 Expansions 287
14.1.2.4 MnM view 287
14.1.2.4.1 Key strengths 287
14.1.2.4.2 Strategic choices 288
14.1.2.4.3 Weaknesses and competitive threats 288
14.1.3 BD 289
14.1.3.1 Business overview 289
14.1.3.2 Products/Solutions/Services offered 290
14.1.3.3 Recent developments 291
14.1.3.3.1 Product launches 291
14.1.3.3.2 Deals 291
14.1.3.3.3 Other developments 291
14.1.3.4 MnM view 292
14.1.3.4.1 Key strengths 292
14.1.3.4.2 Strategic choices 292
14.1.3.4.3 Weaknesses and competitive threats 292
14.1.4 MEDTRONIC 293
14.1.4.1 Business overview 293
14.1.4.2 Products/Solutions/Services offered 294
14.1.4.3 Recent developments 295
14.1.4.3.1 Product approvals 295
14.1.4.3.2 Deals 295
14.1.4.3.3 Expansions 296
14.1.4.4 MnM view 296
14.1.4.4.1 Key strengths 296
14.1.4.4.2 Strategic choices 296
14.1.4.4.3 Weaknesses and competitive threats 296
14.1.5 OMNICELL, INC. 297
14.1.5.1 Business overview 297
14.1.5.2 Products/Solutions/Services offered 298
14.1.5.3 Recent developments 299
14.1.5.3.1 Product launches 299
14.1.5.3.2 Deals 299
14.1.5.3.3 Expansions 300
14.1.5.3.4 Other developments 300
14.1.5.4 MnM view 300
14.1.5.4.1 Key strengths 300
14.1.5.4.2 Strategic choices 301
14.1.5.4.3 Weaknesses and competitive threats 301
14.1.6 ZIMMER BIOMET 302
14.1.6.1 Business overview 302
14.1.6.2 Products/Solutions/Services offered 303
14.1.6.3 Recent developments 304
14.1.6.3.1 Product approvals 304
14.1.6.3.2 Deals 304
14.1.6.3.3 Other developments 305
14.1.7 SMITH+NEPHEW 306
14.1.7.1 Business overview 306
14.1.7.2 Products/Solutions/Services offered 307
14.1.7.3 Recent developments 308
14.1.7.3.1 Product/service launches and enhancements 308
14.1.8 EKSO BIONICS 309
14.1.8.1 Business overview 309
14.1.8.2 Products/Solutions/Services offered 310
14.1.8.3 Recent developments 310
14.1.8.3.1 Product approvals 310
14.1.8.3.2 Deals 311
14.1.8.3.3 Other developments 312
14.1.9 ARXIUM 313
14.1.9.1 Business overview 313
14.1.9.2 Products/Solutions/Services offered 313
14.1.9.3 Recent developments 314
14.1.9.3.1 Product approvals 314
14.1.10 ASENSUS SURGICAL US, INC. (SUBSIDIARY OF KARL STORZ) 315
14.1.10.1 Business overview 315
14.1.10.2 Products/Solutions/Services offered 316
14.1.10.3 Recent developments 316
14.1.10.3.1 Product approvals 316
14.1.10.3.2 Deals 317
14.1.11 RENISHAW PLC 319
14.1.11.1 Business overview 319
14.1.11.2 Products/Services/Solutions offered 320
14.1.11.3 Recent developments 321
14.1.11.3.1 Product approvals 321
14.1.12 SIEMENS HEALTHINEERS AG 322
14.1.12.1 Business overview 322
14.1.12.2 Products/Solutions/Services offered 323
14.1.12.3 Recent developments 324
14.1.12.3.1 Deals 324
14.1.13 KUKA AG 325
14.1.13.1 Business overview 325
14.1.13.2 Products/Solutions/Services offered 327
14.1.14 CMR SURGICAL 328
14.1.14.1 Business overview 328
14.1.14.2 Products/Services offered 328
14.1.14.3 Recent developments 329
14.1.14.3.1 Product approvals 329
14.1.14.3.2 Deals 329
14.1.14.3.3 Other developments 330
14.1.15 ACCURAY INCORPORATED 331
14.1.15.1 Business overview 331
14.1.15.2 Products/Solutions/Services offered 332
14.1.15.3 Recent developments 333
14.1.15.3.1 Product approvals 333
14.1.15.3.2 Deals 333
14.1.15.3.3 Expansions 334
14.1.15.3.4 Other developments 334
14.1.16 DIH MEDICAL 335
14.1.16.1 Business overview 335
14.1.16.2 Products/Solutions/Services offered 336
14.1.16.3 Recent developments 338
14.1.16.3.1 Product approvals 338
14.1.16.3.2 Deals 338
14.1.16.3.3 Other developments 339
14.1.17 JOHNSON & JOHNSON 340
14.1.17.1 Business overview 340
14.1.17.2 Products/Solutions/Services offered 341
14.1.17.3 Recent developments 342
14.1.17.3.1 Product launches & approvals 342
14.1.17.3.2 Other developments 342
14.1.18 CYBERDYNE INC. 343
14.1.18.1 Business overview 343
14.1.18.2 Products/Solutions/Services offered 344
14.1.18.3 Recent developments 345
14.1.18.3.1 Product approvals 345
14.1.18.3.2 Deals 345
14.1.18.3.3 Expansions 346
14.1.19 LIFEWARD, INC. 347
14.1.19.1 Business overview 347
14.1.19.2 Products/Solutions/Services offered 348
14.1.19.3 Recent developments 348
14.1.19.3.1 Product approvals 348
14.1.19.3.2 Deals 349
14.1.20 GLOBUS MEDICAL 350
14.1.20.1 Business overview 350
14.1.20.2 Products/Services/Solutions offered 351
14.1.20.3 Recent developments 352
14.1.20.3.1 Product launches & approvals 352
14.2 OTHER PLAYERS 353
14.2.1 RELAY ROBOTICS, INC. 353
14.3 PROCEPT BIOROBOTICS CORPORATION 354
14.3.1 AETHON, INC. (SUBSIDIARY OF ST ENGINEERING) 355
14.3.2 XENEX DISINFECTION SERVICES INC. 356
14.3.3 ZAP SURGICAL SYSTEMS, INC. 356
15 RESEARCH METHODOLOGY 357
15.1 RESEARCH DATA 357
15.1.1 SECONDARY DATA 358
15.1.1.1 Key data from secondary sources 359
15.1.2 PRIMARY DATA 359
15.1.2.1 Key data from primary sources 360
15.1.2.2 Key industry insights 361
15.2 MARKET SIZE ESTIMATION 361
15.2.1 BOTTOM-UP APPROACH 361
15.2.2 TOP-DOWN APPROACH 362
15.2.3 BASE NUMBER ESTIMATION 362
15.2.3.1 Supply-side analysis (revenue share analysis) 362
15.2.3.2 Company presentations and primary interviews 364
15.3 MARKET FORECAST APPROACH 365
15.4 MARKET BREAKDOWN AND DATA TRIANGULATION 366
15.5 MARKET SHARE ESTIMATION 367
15.6 STUDY ASSUMPTIONS 367
15.7 FACTOR ANALYSIS 368
15.8 RESEARCH LIMITATIONS 368
15.8.1 SCOPE-RELATED LIMITATIONS 368
15.8.2 METHODOLOGY-RELATED LIMITATIONS 368
15.9 RISK ASSESSMENT 369
16 APPENDIX 370
16.1 DISCUSSION GUIDE 370
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 375
16.3 CUSTOMIZATION OPTIONS 377
16.4 RELATED REPORTS 377
16.5 AUTHOR DETAILS 378

ページTOPに戻る

List of Tables/Graphs

TABLE 1 STANDARD CURRENCY CONVERSION RATES 37.
TABLE 2 GROWTH RATE IN GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 51.
TABLE 3 PER CAPITA NATIONAL INCOME, BY COUNTRY, 2020–2023 (USD) 57.
TABLE 4 MEDICAL ROBOTS MARKET: PORTER’S FIVE FORCES ANALYSIS 62.
TABLE 5 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 65.
TABLE 6 CPT CODES AND REIMBURSEMENT ANALYSIS FOR DA VINCI SURGICAL SYSTEM IN US 68.
TABLE 7 REGIONAL PRICING ANALYSIS OF MEDICAL ROBOTIC SYSTEMS, BY TYPE, 2025 72.
TABLE 8 AVERAGE SELLING PRICE OF MEDICAL ROBOTS, BY TYPE, 2025 73.
TABLE 9 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 73.
TABLE 10 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 74.
TABLE 11 MEDICAL ROBOTS MARKET: LIST OF KEY CONFERENCES & EVENTS, 2026–2027 74.
TABLE 12 US-ADJUSTED RECIPROCAL TARIFF RATES 78.
TABLE 13 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR MEDICAL ROBOTS 79.
TABLE 14 TOP USE CASES AND MARKET POTENTIAL 87.
TABLE 15 MEDICAL ROBOTS MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 88.
TABLE 16 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS 89.
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90.
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90.
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91.
TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92.
TABLE 21 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92.
TABLE 22 US FDA: MEDICAL DEVICE CLASSIFICATION 93.
TABLE 23 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 94.
TABLE 24 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 95.
TABLE 25 CHINA: CLASSIFICATION OF MEDICAL DEVICES 95.
TABLE 26 GLOBAL STANDARDS IN MEDICAL ROBOTS MARKET 97.
TABLE 27 CERTIFICATIONS, LABELING, & ECO-STANDARDS IN MEDICAL ROBOTS MARKET 98.
TABLE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER 101.
TABLE 29 KEY BUYING CRITERIA FOR END USERS 102.
TABLE 30 MEDICAL ROBOTS MARKET: UNMET NEEDS/END-USER EXPECTATIONS 103.
TABLE 31 MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 106.
TABLE 32 MEDICAL ROBOT INSTRUMENTS & ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 107.
TABLE 33 MEDICAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 108.
TABLE 34 MEDICAL ROBOTIC SYSTEMS MARKET, BY REGION, 2024–2031 (UNITS) 109.
TABLE 35 MEDICAL ROBOT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110.
TABLE 36 MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 112.
TABLE 37 SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 113.
TABLE 38 SURGICAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 114.
TABLE 39 SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 115.
TABLE 40 SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY COUNTRY, 2024–2031 (USD MILLION) 115.
TABLE 41 SURGICAL ROBOTIC SYSTEMS MARKET FOR GENERAL SURGERY, BY COUNTRY, 2024–2031 (USD MILLION) 117.
TABLE 42 SURGICAL ROBOTIC SYSTEMS MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2024–2031 (USD MILLION) 119.
TABLE 43 SURGICAL ROBOTIC SYSTEMS MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2024–2031 (USD MILLION) 121.
TABLE 44 SURGICAL ROBOTIC SYSTEMS MARKET FOR OTHER SOFT TISSUE SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION) 122.
TABLE 45 SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 123.
TABLE 46 SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY COUNTRY, 2024–2031 (USD MILLION) 124.
TABLE 47 SURGICAL ROBOTIC SYSTEMS MARKET FOR KNEE & HIP SURGERY, BY COUNTRY, 2024–2031 (USD MILLION) 126.
TABLE 48 SURGICAL ROBOTIC SYSTEMS MARKET FOR SPINE SURGERY, BY COUNTRY, 2024–2031 (USD MILLION) 128.
TABLE 49 SURGICAL ROBOTIC SYSTEMS MARKET FOR OTHER HARD TISSUE SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION) 129.
TABLE 50 REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 130.
TABLE 51 REHABILITATION ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130.
TABLE 52 THERAPEUTIC ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132.
TABLE 53 ASSISTIVE ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133.
TABLE 54 EXOSKELETON ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134.
TABLE 55 OTHER REHABILITATION ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135.
TABLE 56 RADIOSURGERY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136.
TABLE 57 HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 137.
TABLE 58 HOSPITAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138.
TABLE 59 DELIVERY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139.
TABLE 60 TELEPRESENCE ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140.
TABLE 61 DIAGNOSTIC ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142.
TABLE 62 OTHER HOSPITAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143.
TABLE 63 PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 144.
TABLE 64 PHARMACY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145.
TABLE 65 POPULAR ROBOTIC AUTOMATED DISPENSING SYSTEMS AVAILABLE IN MARKET 146.
TABLE 66 ROBOTIC DISPENSING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146.
TABLE 67 POPULAR COMPOUNDING ROBOTIC SYSTEMS AVAILABLE IN MARKET 147.
TABLE 68 COMPOUNDING ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148.
TABLE 69 OTHER PHARMACY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149.
TABLE 70 MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 151.
TABLE 71 LIST OF RECENTLY INSTALLED ROBOTIC SYSTEMS IN HOSPITALS 152.
TABLE 72 MEDICAL ROBOTS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 153.
TABLE 73 MEDICAL ROBOTS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 154.
TABLE 74 MEDICAL ROBOTS MARKET FOR PHARMACIES, BY COUNTRY, 2024–2031 (USD MILLION) 156.
TABLE 75 MEDICAL ROBOTS MARKET FOR REHABILITATION CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 157.
TABLE 76 MEDICAL ROBOTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 159.
TABLE 77 MEDICAL ROBOTS MARKET, BY REGION, 2024–2031 (USD MILLION) 162.
TABLE 78 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163.
TABLE 79 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 164.
TABLE 80 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 164.
TABLE 81 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 164.
TABLE 82 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 165.
TABLE 83 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 165.
TABLE 84 NORTH AMERICA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 165.
TABLE 85 NORTH AMERICA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 166.
TABLE 86 NORTH AMERICA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 166.
TABLE 87 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 166.
TABLE 88 US: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 168.
TABLE 89 US: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 168.
TABLE 90 US: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 168.
TABLE 91 US: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 169.
TABLE 92 US: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 169.
TABLE 93 US: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 169.
TABLE 94 US: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 170.
TABLE 95 US: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 170.
TABLE 96 US: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 170.
TABLE 97 CANADA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 171.
TABLE 98 CANADA: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 172.
TABLE 99 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 172.
TABLE 100 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 172.
TABLE 101 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 173.
TABLE 102 CANADA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 173.
TABLE 103 CANADA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 173.
TABLE 104 CANADA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 174.
TABLE 105 CANADA: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 174.
TABLE 106 EUROPE: MEDICAL ROBOTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 175.
TABLE 107 EUROPE: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 175.
TABLE 108 EUROPE: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 176.
TABLE 109 EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 176.
TABLE 110 EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 176.
TABLE 111 EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 177.
TABLE 112 EUROPE: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 177.
TABLE 113 EUROPE: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 177.
TABLE 114 EUROPE: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 178.
TABLE 115 EUROPE: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 178.
TABLE 116 GERMANY: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 179.
TABLE 117 GERMANY: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 179.
TABLE 118 GERMANY: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 180.
TABLE 119 GERMANY: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 180.
TABLE 120 GERMANY: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 180.
TABLE 121 GERMANY: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 181.
TABLE 122 GERMANY: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 181.
TABLE 123 GERMANY: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 181.
TABLE 124 GERMANY: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 182.
TABLE 125 UK: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 183.
TABLE 126 UK: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 183.
TABLE 127 UK: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 184.
TABLE 128 UK: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 184.
TABLE 129 UK: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 184.
TABLE 130 UK: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 185.
TABLE 131 UK: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 185.
TABLE 132 UK: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 185.
TABLE 133 UK: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 186.
TABLE 134 FRANCE: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 187.
TABLE 135 FRANCE: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 187.
TABLE 136 FRANCE: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 187.
TABLE 137 FRANCE: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 188.
TABLE 138 FRANCE: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 188.
TABLE 139 FRANCE: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 188.
TABLE 140 FRANCE: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 189.
TABLE 141 FRANCE: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 189.
TABLE 142 FRANCE: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 189.
TABLE 143 ITALY: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 190.
TABLE 144 ITALY: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 191.
TABLE 145 ITALY: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 191.
TABLE 146 ITALY: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 191.
TABLE 147 ITALY: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 192.
TABLE 148 ITALY: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 192.
TABLE 149 ITALY: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 192.
TABLE 150 ITALY: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 193.
TABLE 151 ITALY: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 193.
TABLE 152 SPAIN: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 194.
TABLE 153 SPAIN: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 194.
TABLE 154 SPAIN: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 194.
TABLE 155 SPAIN: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 195.
TABLE 156 SPAIN: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 195.
TABLE 157 SPAIN: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 195.
TABLE 158 SPAIN: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 196.
TABLE 159 SPAIN: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 196.
TABLE 160 SPAIN: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 196.
TABLE 161 REST OF EUROPE: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 197.
TABLE 162 REST OF EUROPE: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 198.
TABLE 163 REST OF EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 198.
TABLE 164 REST OF EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 198.
TABLE 165 REST OF EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 199.
TABLE 166 REST OF EUROPE: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 199.
TABLE 167 REST OF EUROPE: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 199.
TABLE 168 REST OF EUROPE: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 200.
TABLE 169 REST OF EUROPE: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 200.
TABLE 170 ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203.
TABLE 171 ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 203.
TABLE 172 ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 204.
TABLE 173 ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 204.
TABLE 174 ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 204.
TABLE 175 ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 205.
TABLE 176 ASIA PACIFIC: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 205.
TABLE 177 ASIA PACIFIC: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 205.
TABLE 178 ASIA PACIFIC: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 206.
TABLE 179 ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 206.
TABLE 180 JAPAN: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 207.
TABLE 181 JAPAN: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 207.
TABLE 182 JAPAN: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 208.
TABLE 183 JAPAN: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 208.
TABLE 184 JAPAN: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 208.
TABLE 185 JAPAN: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 209.
TABLE 186 JAPAN: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 209.
TABLE 187 JAPAN: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 209.
TABLE 188 JAPAN: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 210.
TABLE 189 CHINA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 211.
TABLE 190 CHINA: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 211.
TABLE 191 CHINA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 211.
TABLE 192 CHINA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 212.
TABLE 193 CHINA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 212.
TABLE 194 CHINA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 212.
TABLE 195 CHINA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 213.
TABLE 196 CHINA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 213.
TABLE 197 CHINA: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 213.
TABLE 198 INDIA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 214.
TABLE 199 INDIA: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 215.
TABLE 200 INDIA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 215.
TABLE 201 INDIA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 215.
TABLE 202 INDIA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 216.
TABLE 203 INDIA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 216.
TABLE 204 INDIA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 216.
TABLE 205 INDIA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 217.
TABLE 206 INDIA: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 217.
TABLE 207 SOUTH KOREA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 218.
TABLE 208 SOUTH KOREA: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218.
TABLE 209 SOUTH KOREA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 219.
TABLE 210 SOUTH KOREA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 219.
TABLE 211 SOUTH KOREA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 219.
TABLE 212 SOUTH KOREA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 220.
TABLE 213 SOUTH KOREA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 220.
TABLE 214 SOUTH KOREA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 220.
TABLE 215 SOUTH KOREA: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 221.
TABLE 216 AUSTRALIA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 222.
TABLE 217 AUSTRALIA: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 222.
TABLE 218 AUSTRALIA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 222.
TABLE 219 AUSTRALIA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 223.
TABLE 220 AUSTRALIA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 223.
TABLE 221 AUSTRALIA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223.
TABLE 222 AUSTRALIA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 224.
TABLE 223 AUSTRALIA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 224.
TABLE 224 AUSTRALIA: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 224.
TABLE 225 REST OF ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 225.
TABLE 226 REST OF ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 226.
TABLE 227 REST OF ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 226.
TABLE 228 REST OF ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 226.
TABLE 229 REST OF ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 227.
TABLE 230 REST OF ASIA PACIFIC: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 227.
TABLE 231 REST OF ASIA PACIFIC: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 227.
TABLE 232 REST OF ASIA PACIFIC: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228.
TABLE 233 REST OF ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 228.
TABLE 234 LATIN AMERICA: MEDICAL ROBOTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 229.
TABLE 235 LATIN AMERICA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 230.
TABLE 236 LATIN AMERICA: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 230.
TABLE 237 LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 230.
TABLE 238 LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 231.
TABLE 239 LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 231.
TABLE 240 LATIN AMERICA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 231.
TABLE 241 LATIN AMERICA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232.
TABLE 242 LATIN AMERICA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232.
TABLE 243 LATIN AMERICA: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 232.
TABLE 244 BRAZIL: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 233.
TABLE 245 BRAZIL: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 233.
TABLE 246 BRAZIL: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 234.
TABLE 247 BRAZIL: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 234.
TABLE 248 BRAZIL: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 234.
TABLE 249 BRAZIL: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 235.
TABLE 250 BRAZIL: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 235.
TABLE 251 BRAZIL: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 235.
TABLE 252 BRAZIL: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 236.
TABLE 253 MEXICO: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 236.
TABLE 254 MEXICO: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 237.
TABLE 255 MEXICO: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 237.
TABLE 256 MEXICO: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 237.
TABLE 257 MEXICO: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 238.
TABLE 258 MEXICO: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238.
TABLE 259 MEXICO: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238.
TABLE 260 MEXICO: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 239.
TABLE 261 MEXICO: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 239.
TABLE 262 REST OF LATIN AMERICA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 240.
TABLE 263 REST OF LATIN AMERICA: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 240.
TABLE 264 REST OF LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 240.
TABLE 265 REST OF LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 241.
TABLE 266 REST OF LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 241.
TABLE 267 REST OF LATIN AMERICA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 241.
TABLE 268 REST OF LATIN AMERICA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242.
TABLE 269 REST OF LATIN AMERICA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242.
TABLE 270 REST OF LATIN AMERICA: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 242.
TABLE 271 MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY REGION, 2024–2031 (USD MILLION) 244.
TABLE 272 MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 244.
TABLE 273 MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 244.
TABLE 274 MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 245.
TABLE 275 MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 245.
TABLE 276 MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 245.
TABLE 277 MIDDLE EAST & AFRICA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 246.
TABLE 278 MIDDLE EAST & AFRICA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 246.
TABLE 279 MIDDLE EAST & AFRICA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 246.
TABLE 280 MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 247.
TABLE 281 GCC COUNTRIES: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 248.
TABLE 282 GCC COUNTRIES: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 248.
TABLE 283 GCC COUNTRIES: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 248.
TABLE 284 GCC COUNTRIES: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 249.
TABLE 285 GCC COUNTRIES: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 249.
TABLE 286 GCC COUNTRIES: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 249.
TABLE 287 GCC COUNTRIES: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250.
TABLE 288 GCC COUNTRIES: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250.
TABLE 289 GCC COUNTRIES: MEDICAL ROBOTS MARKET, BY END USER, 2024–2031 (USD MILLION) 250.
TABLE 290 REST OF MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 251.
TABLE 291 REST OF MIDDLE EAST & AFRICA: MEDICAL ROBOTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 252.
TABLE 292 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 252.
TABLE 293 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 252.
TABLE 294 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2024–2031 (USD MILLION) 253.
TABLE 295 REST OF MIDDLE EAST & AFRICA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 253.
TABLE 296 REST OF MIDDLE EAST & AFRICA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 253.
FIGURE 1 MARKET SCENARIO 40.
FIGURE 2 MEDICAL ROBOTS MARKET, 2026–2031 (USD MILLION) 41.
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL ROBOTS MARKET, 2022–2026 42.
FIGURE 4 DISRUPTIVE TRENDS IMPACTING GROWTH OF MEDICAL ROBOTS MARKET 43.
FIGURE 5 HIGH-GROWTH SEGMENTS IN MEDICAL ROBOTS MARKET, 2026–2031 44.
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 45.
FIGURE 7 INCREASING VOLUME OF SURGERIES AND RISING GERIATRIC POPULATION TO DRIVE MARKET 46.
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING STUDY PERIOD 47.
FIGURE 9 INSTRUMENTS & ACCESSORIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 48.
FIGURE 10 INDIA TO REGISTER HIGHEST CAGR FROM 2026 TO 2031 49.
FIGURE 11 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 49.
FIGURE 12 MEDICAL ROBOTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50.
FIGURE 13 MEDICAL ROBOTS MARKET: PORTER’S FIVE FORCES ANALYSIS 63.
FIGURE 14 MEDICAL ROBOTS MARKET: VALUE CHAIN ANALYSIS 71.
FIGURE 15 MEDICAL ROBOTS MARKET: ECOSYSTEM 72.
FIGURE 16 MEDICAL ROBOTS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 75.
FIGURE 17 INVESTMENT/VENTURE CAPITAL SCENARIO IN MEDICAL ROBOTS MARKET, 2022–2025 77.
FIGURE 18 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL ROBOTS MARKET, JANUARY 2015–DECEMBER 2025 85.
FIGURE 19 TOP PATENT APPLICANT COUNTRIES FOR MEDICAL ROBOTS (JANUARY 2015–DECEMBER 2025) 86.
FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 100.
FIGURE 21 KEY BUYING CRITERIA FOR END USERS 101.
FIGURE 22 NUMBER OF NEW GYNECOLOGICAL CANCER CASES, 2022 VS. 2045 118.
FIGURE 23 NUMBER OF NEW UROLOGICAL CANCER CASES, 2022 VS. 2045 120.
FIGURE 24 HIP REPLACEMENT SURGICAL PROCEDURES, BY COUNTRY, 2013 VS. 2023 125.
FIGURE 25 KNEE REPLACEMENT SURGICAL PROCEDURES, BY COUNTRY, 2013 VS. 2023 126.
FIGURE 26 INDIA TO REGISTER HIGHEST GROWTH IN MEDICAL ROBOTS MARKET DURING FORECAST PERIOD 161.
FIGURE 27 NORTH AMERICA: MEDICAL ROBOTS MARKET SNAPSHOT 163.
FIGURE 28 ASIA PACIFIC: MEDICAL ROBOTS MARKET SNAPSHOT 202.
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL ROBOTS MARKET, 2021−2025 257.
FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SURGICAL ROBOTS MARKET, 2025 258.
FIGURE 31 MARKET SHARE ANALYSIS FOR KEY PLAYERS IN HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET, 2025 261.
FIGURE 32 MEDICAL ROBOTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 263.
FIGURE 33 MEDICAL ROBOTS MARKET: COMPANY FOOTPRINT 264.
FIGURE 34 MEDICAL ROBOTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 270.
FIGURE 35 MEDICAL ROBOTS MARKET: BRAND COMPARISON 272.
FIGURE 36 EV/EBITDA OF KEY VENDORS 273.
FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 273.
FIGURE 38 INTUITIVE SURGICAL, INC.: COMPANY SNAPSHOT (2025) 279.
FIGURE 39 STRYKER: COMPANY SNAPSHOT (2025) 285.
FIGURE 40 BD: COMPANY SNAPSHOT (2025) 290.
FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT (2025) 294.
FIGURE 42 OMNICELL, INC. COMPANY SNAPSHOT (2025) 298.
FIGURE 43 ZIMMER BIOMET: COMPANY SNAPSHOT (2025) 303.
FIGURE 44 SMITH+NEPHEW: COMPANY SNAPSHOT (2025) 307.
FIGURE 45 EKSO BIONICS: COMPANY SNAPSHOT (2025) 309.
FIGURE 46 RENISHAW PLC: COMPANY SNAPSHOT (2025) 320.
FIGURE 47 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025) 323.
FIGURE 48 KUKA AG: COMPANY SNAPSHOT (2025) 326.
FIGURE 49 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2025) 332.
FIGURE 50 DIH MEDICAL: COMPANY SNAPSHOT (2025) 336.
FIGURE 51 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2025) 341.
FIGURE 52 CYBERDYNE INC.: COMPANY SNAPSHOT (2025) 344.
FIGURE 53 LIFEWARD, INC.: COMPANY SNAPSHOT (2025) 347.
FIGURE 54 GLOBUS MEDICAL: COMPANY SNAPSHOT 351.
FIGURE 55 RESEARCH DESIGN 357.
FIGURE 56 PRIMARY SOURCES 359.
FIGURE 57 BOTTOM-UP APPROACH 362.
FIGURE 58 TOP-DOWN APPROACH 362.
FIGURE 59 SUPPLY-SIDE MEDICAL ROBOTS MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 363.
FIGURE 60 REVENUE SHARE ANALYSIS ILLUSTRATION: STRYKER 363.
FIGURE 61 SUPPLY-SIDE ANALYSIS: MEDICAL ROBOTS MARKET (2025) 364.
FIGURE 62 MEDICAL ROBOTS MARKET: CAGR PROJECTIONS 365.
FIGURE 63 DATA TRIANGULATION METHODOLOGY 366.